Open AccessPCM-13THE HYPOXIA-ACTIVATED PRODRUG EVOFOSFAMIDE (TH-302) IS EFFICACIOUS IN PEDIATRIC HIGH GRADE GLIOMA CELL LINES AS A MONOTHERAPY AND IN COMBINATION WITH CHEMOTHERAPIES
Author(s) -
Pierre Leblond,
Pauline Navarin,
Mélanie Arcicasa,
Christine Bal-Mahieu,
Nicole Lemahieu,
Pamela Völkel,
Éric Lartigau,
PierreOlivier Angrand,
Samuel Meignan
Publication year - 2016
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/now080.13
Subject(s) - prodrug , hypoxia (environmental) , glioma , pharmacology , medicine , cancer research , chemistry , oxygen , organic chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom